Clinical Trials Directory

Trials / Sponsors / Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Academic / Other · 11 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil
Diabete Type 2
Phase 12026-06-01
RecruitingThe Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）
Obesity and Overweight
Phase 22025-08-25
Not Yet RecruitingEfficacy and Safety of Efsubaglutide Alfa Injection 3 Mg Q2W in T2D Patients
Type 2 Diabetes
Phase 32025-07-30
Active Not RecruitingThe Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
Obesity and Overweight
Phase 2 / Phase 32025-03-31
CompletedA Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients
Type2 Diabetes
Phase 22024-12-18
CompletedA Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients
Overweight or Obesity
Phase 22024-04-21
CompletedDrug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin
Healthy Volunteers
Phase 12023-03-20
CompletedA Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Type2 Diabetes
Phase 2 / Phase 32021-10-12
CompletedA Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)
Type2 Diabetes
Phase 2 / Phase 32021-08-03
CompletedA Study of Supaglutide in Chinese Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
Phase 22020-04-14
CompletedA Study of the Efficacy and Safety of Supaglutide in Healthy Participants
Diabetes Mellitus, Type 2
Phase 12018-12-04